Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,120 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $242.00 | 2 | $0 (2020) |
| GRT US Holding, Inc. | $195.00 | 2 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $171.22 | 2 | $0 (2022) |
| Novo Nordisk Inc | $136.77 | 2 | $0 (2022) |
| Abbott Laboratories | $105.24 | 5 | $0 (2024) |
| PFIZER INC. | $94.55 | 4 | $0 (2021) |
| ABBVIE INC. | $93.33 | 2 | $0 (2024) |
| Exact Sciences Corporation | $23.64 | 1 | $0 (2024) |
| Indivior Inc. | $18.71 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $14.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167.33 | 5 | ABBVIE INC. ($93.33) |
| 2023 | $38.82 | 2 | Abbott Laboratories ($38.82) |
| 2022 | $402.24 | 6 | GRT US Holding, Inc. ($195.00) |
| 2021 | $106.95 | 5 | PFIZER INC. ($94.55) |
| 2020 | $242.00 | 2 | GlaxoSmithKline, LLC. ($242.00) |
| 2018 | $116.81 | 1 | Collegium Pharmaceutical, Inc. ($116.81) |
| 2017 | $46.19 | 3 | Indivior Inc. ($18.71) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Diabetes Care | ||||||
| 07/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Oncology | ||||||
| 04/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Diabetes Care | ||||||
| 04/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 04/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.33 | General |
| 10/17/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Diabetes Care | ||||||
| 07/14/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes Care | ||||||
| 09/07/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Pain Management | ||||||
| 09/07/2022 | Collegium Pharmaceutical, Inc. | BELBUCA (Drug), Xtampza | Food and Beverage | Cash or cash equivalent | $54.41 | General |
| Category: Opioid Analgesic | ||||||
| 09/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Pain Management | ||||||
| 03/31/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $120.17 | General |
| Category: Diabetes | ||||||
| 03/22/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes Care | ||||||
| 03/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/31/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/18/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Virology & Specialty Care | ||||||
| 01/11/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/06/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $117.77 | General |
| Category: RESPIRATORY | ||||||
| 09/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.23 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2018 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $116.81 | General |
| Category: Opioid Analgesic | ||||||
| 08/31/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: OUD | ||||||
| 08/23/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: DIABETES | ||||||
| 05/01/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 543 | 960 | $207,281 | $69,246 |
| 2022 | 11 | 550 | 965 | $186,540 | $74,086 |
| 2021 | 9 | 398 | 856 | $162,695 | $68,618 |
| 2020 | 11 | 398 | 996 | $194,350 | $69,817 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 432 | $110,592 | $35,555 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 139 | $50,457 | $16,103 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $15,399 | $7,418 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 62 | $11,284 | $3,775 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,112 | $1,525 | 18.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 55 | 55 | $2,915 | $1,409 | 48.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $2,376 | $1,168 | 49.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 64 | 64 | $1,600 | $1,133 | 70.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 19 | $2,546 | $779.89 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 28 | $1,400 | $270.72 | 19.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $600.00 | $109.00 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 451 | $101,393 | $37,781 | 37.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 152 | $47,657 | $19,315 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $15,854 | $8,644 | 54.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 33 | $5,698 | $2,117 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,650 | $1,487 | 26.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 72 | 72 | $2,360 | $1,311 | 55.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 67 | 67 | $2,364 | $1,199 | 50.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 44 | 44 | $2,245 | $1,157 | 51.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $750.00 | $432.26 | 57.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $1,040 | $337.44 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 31 | $1,529 | $305.99 | 20.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 571 | $122,765 | $50,442 | 41.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 58 | $16,820 | $7,506 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 46 | 46 | $10,960 | $6,064 | 55.3% |
About Dr. Mario Perez-Rodriguez, M.D
Dr. Mario Perez-Rodriguez, M.D is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528052420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Perez-Rodriguez, M.D has received a total of $1,120 in payments from pharmaceutical and medical device companies, with $167.33 received in 2024. These payments were reported across 24 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,120).
As a Medicare-enrolled provider, Perez-Rodriguez has provided services to 1,889 Medicare beneficiaries, totaling 3,777 services with total Medicare billing of $281,766. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Clermont, FL
- Active Since 09/07/2005
- Last Updated 12/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528052420
Products in Payments
- Qutenza (Drug) $195.00
- Rybelsus (Drug) $136.77
- TRELEGY ELLIPTA (Drug) $124.23
- NUCALA (Biological) $117.77
- Xtampza ER (Drug) $116.81
- ELIQUIS (Drug) $94.55
- FREESTYLE LIBRE 2 (Device) $54.88
- BELBUCA (Drug) $54.41
- FREESTYLE LIBRE 3 (Device) $50.36
- Cologuard Collection Kit (Device) $23.64
- SUBOXONE SUBLINGUAL FILM (Drug) $18.71
- TOUJEO (Drug) $14.74
- XARELTO (Drug) $12.74
- Xofluza (Drug) $12.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Dr. Shazia Nasir, Md, MD
Internal Medicine — Payments: $11,207
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620